Emil N. is an experienced leader in health-tech and biopharma, specializing in commercialization, market access, pricing, contracting, and drug launch strategies. With over 17 years in the industry, Emil has worked with major global clients across diverse therapeutic areas and has developed country-specific pricing strategies for innovative therapies. Emil's leadership roles include Principal at Arthur D. Little and Director at Gilead Sciences, where they focused on market strategies and analytics. Emil holds an MBA from Columbia Business School and a BBA from The George Washington University, demonstrating a strong academic foundation in finance and international business. Currently, Emil serves as a Senior Director at EY, further advancing their career in life sciences value and access.
This person is not in the org chart
This person is not in any teams
This person is not in any offices